Company’s 36-month beta value is 2.92.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HSCS is 0.82M, and currently, short sellers hold a 6.70% ratio of that floaft. The average trading volume of HSCS on December 20, 2024 was 338.41K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HSCS) stock’s latest price update
The stock price of HeartSciences Inc (NASDAQ: HSCS) has dropped by -9.04 compared to previous close of 3.76. Despite this, the company has seen a fall of -15.97% in its stock price over the last five trading days. globenewswire.com reported 2024-12-16 that Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the second quarter fiscal 2025 ended October 31, 2024 and provided a business update.
HSCS’s Market Performance
HSCS’s stock has fallen by -15.97% in the past week, with a monthly rise of 29.55% and a quarterly rise of 14.38%. The volatility ratio for the week is 11.97% while the volatility levels for the last 30 days are 10.97% for HeartSciences Inc The simple moving average for the past 20 days is -2.94% for HSCS’s stock, with a -39.01% simple moving average for the past 200 days.
HSCS Trading at 5.29% from the 50-Day Moving Average
After a stumble in the market that brought HSCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.51% of loss for the given period.
Volatility was left at 10.97%, however, over the last 30 days, the volatility rate increased by 11.97%, as shares surge +29.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.38% lower at present.
During the last 5 trading sessions, HSCS fell by -15.97%, which changed the moving average for the period of 200-days by -73.69% in comparison to the 20-day moving average, which settled at $3.52. In addition, HeartSciences Inc saw -80.00% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HSCS
Current profitability levels for the company are sitting at:
- -135409.1 for the present operating margin
- -2.46 for the gross margin
The net margin for HeartSciences Inc stands at -142072.09. The total capital return value is set at -0.44. Equity return is now at value -644.23, with -150.30 for asset returns.
Based on HeartSciences Inc (HSCS), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at -1.45. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 16.95.
Currently, EBITDA for the company is -6.16 million with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of -77932.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.
Conclusion
In a nutshell, HeartSciences Inc (HSCS) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
